A product-level review of the compounded prescription, billing conditions, customer survey and testing claims.
- Product category
- Compounded prescription
- Introductory condition
- $99 first month; three-month prepayment
- Subsequent quote
- $149/month in purchase-section wording
The supplied preparation and the research are separate
AgelessRx describes Sermorelin Injection as a compounded prescription supplied after an online evaluation. Its page discusses growth-hormone signaling and potential wellness benefits. Those descriptions explain the marketing rationale; they do not establish that the dispensed formulation has FDA approval or that a reader has a condition requiring it.[source][source]
A useful consultation should identify the goal, the reason for the proposed medicine and how the clinician would judge whether continuing is appropriate. This review does not provide injection instructions, choose a schedule or interpret laboratory results.
The first-month offer does not settle the first bill
The purchase section states $99 for the first month, attached to a three-month plan billed in full, with $149 per month afterward. Ask for the complete initial charge and the exact timing of the higher rate. We do not assume that the opening “starting at” figure applies equally to every month in the first package.[source]
The page advertises messaging, adjustments, ongoing check-ins and free shipping. Confirm the monitoring arrangement and any laboratory charges for the proposed care plan. Also distinguish stopping future renewals from receiving a refund on an already paid prescription.
What the survey can and cannot say
The manufacturer describes self-reported data from 392 prescribed customers who completed check-ins during a stated period. That helps explain where the satisfaction-style results come from. It does not reveal an untreated comparison group or establish that the medicine caused every reported improvement.[source]
The scientific references on the page include different research designs and populations. A mechanism, a small historical study and a modern customer survey answer different questions. None should be combined into a guaranteed outcome timeline for the current commercial preparation.
Testing claims need the right interpretation
Purity, potency and sterility claims concern aspects of product quality. They are not evidence that a treatment extends life or improves a particular symptom. Ask whether the dispensing pharmacy can explain the product label, storage instructions and applicable quality documentation. We have not reviewed a lot-specific certificate or performed laboratory testing.[source]
The comparison with CoreAge Rx sermorelin is therefore a comparison of documented offerings, pricing questions and care access. It is not a finding that one compounded product is safer or clinically superior. The evidence guide shows how to keep those claims separate.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- AgelessRx: Sermorelin Injection pricing, evidence notes and safety informationManufacturer claims and a customer survey are not independent evidence of clinical benefit. The first-month price has a three-month billing condition. · Checked October 10, 2026
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations · Checked October 10, 2026